Pasithea Therapeutics Corp.
KTTA
$1.16
-$0.03-2.36%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 5.42% | -14.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.97% | 3.04% | |||
| Operating Income | 17.97% | -3.04% | |||
| Income Before Tax | 18.27% | -4.29% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 18.27% | -4.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 18.27% | -4.29% | |||
| EBIT | 17.97% | -3.04% | |||
| EBITDA | 19.32% | -3.18% | |||
| EPS Basic | 38.04% | 59.12% | |||
| Normalized Basic EPS | 38.06% | 59.12% | |||
| EPS Diluted | 38.04% | 59.12% | |||
| Normalized Diluted EPS | 38.06% | 59.12% | |||
| Average Basic Shares Outstanding | 31.95% | 155.12% | |||
| Average Diluted Shares Outstanding | 31.95% | 155.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||